News

Find News

Filter articles

Applied Filters

Showing 121 to 127 of 127 results

Australian bid for OxyContin generic dismissed

Australia12-07-2013Legal developments

The Federal Court of Australia has dismissed Spirit Pharmaceutical’s bid to introduce a generic version of painkiller OxyContin.

IPAB sets aside Sutent patent rejection

India07-06-2013

India’s Intellectual Property Appellate Board has set aside a decision revoking a Pfizer-licensed patent directed to cancer drug Sutent.

Amgen and Astellas join forces in Japan

Japan, US30-05-2013

California-based biotechnology company Amgen has entered into a long-term partnership with Japanese pharmaceutical company Astellas Pharmas Inc to provide new medicines in Japan.

Mylan signs generic truce with Shionogi and Andrx

Japan, US15-03-2013

Generic drug maker Mylan has struck a deal with pharma companies Shionogi and Andrx to resolve a patent dispute over their diabetes drug Fortamet.

Australian Myriad ruling to face appeal

05-03-2013

Law firm Maurice Blackburn revealed on Monday that it will appeal against an Australian court decision that backed Myriad Genetics’ ownership of a human gene mutation linked to breast cancer.

BRICK nations catching up on patents, as Brazil looks to life sciences

Brazil, China, India, Russia, South Korea25-02-2013

In a report published by Thomson Reuters on February 20, the BRICK nations were shown to be filing almost as many patents as the G7 nations in 2011.

Australian court backs Myriad in human gene patent dispute

Australia18-02-2013

A judge at Australia’s Federal Court has upheld Myriad Genetics’ patent covering a human gene mutation linked to breast cancer, in the country’s first court ruling on whether isolated genes can be patented.

Showing 121 to 127 of 127 results

LSIPR